We are delighted to welcome Dr Shankar Swaminathan, Ph.D. as a new guest blogger here at medicalnanotec.com. Dr. Swaminathan is curently a Post-Doctoral research fellow at the Hamilton Eye Institute, University of Tennessee.
- In a nutshell, Dr. Swaminathan is a pharmaceutical scientist and polymer chemist turned into an eye/vision researcher. Dr. Swaminathan received his Ph.D. in Pharmaceutics from the Institute of Chemical Technology, Mumbai, India. He was also a research assistant at the University of Turin, Italy during his Ph.D. He went on to gain research experience in the industry after his Ph.D. specializing in long acting polymeric medical devices for contraception where he was instrumental in getting the product to the scale up stage. He then decided to fortify his repertoire further by gaining postdoctoral research experience in the US in eye/vision research.
- Currently, a postdoctoral researcher at the University of Tennessee Health Science Center. His research revolves around studying genetic modifiers of glaucoma with a special emphasis on intraocular pressure and developing personalized nanomedicine. Research involves gene mining using bioinformatics tools and systems genetics. He is also a part of the team developing novel nano-therapies for dry age related macular degeneration.
- Pioneered the work on Nanosponge synthesis and applications in drug delivery.
- Over the years, contributed towards research in drug delivery technology, nanotechnology, ocular drug delivery, ocular pharmacokinetics, systems biology, bioinformatics, solublization of drug actives, medical devices, etc.
- General research interests revolve around providing value added medicine to alleviate diseases by applying polymeric nanoparticle technology, controlled drug delivery, solubilization, cyclodextrin based drug delivery systems, ocular pharmacokinetics and biodistribution. Solid dispersion, drug/particle/pellet coating, pellets into tablet technology, Silicone based controlled release medical devices for contraception, Intrauterine medical devices, anticancer drug therapy optimization by solubilization and bioavailability enhancement, stabilization of macrocmolecules/proteins by use of nanosponge technology, physicochemical stabilization of molecules.
- He is also interested in the commercial aspects of research dealing with bench to market transition of a product, and product licensing. He has keen interest in the FDA regulations and IP related issues pertaining to product filings.
To find out more about Dr. Swaminathan